Global Propofol Drug Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Global Propofol Drug Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Propofol Drug market size was valued at US$ 1399 million in 2024 and is forecast to a readjusted size of USD 1751 million by 2031 with a CAGR of 3.3% during review period.

Propofol drug is a short-acting, intravenous anesthetic agent used for the induction and maintenance of general anesthesia, sedation for mechanically ventilated adults, and procedural sedation. Propofol has the advantages of fast onset of anesthesia induction, rapid awakening, perfect functional recovery, and low incidence of adverse reactions such as postoperative nausea and vomiting.

The largest manufacturer of Propofol Drug in the U.S. region is Fresenius Kabi, which holds about 71% share. In terms of product type, 20 mL is the largest segment, accounting for a share of 55%. In terms of application, General Anesthesia is the largest field with a share about 64 percent.

This report is a detailed and comprehensive analysis for global Propofol Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Propofol Drug market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2020-2031

Global Propofol Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2020-2031

Global Propofol Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2020-2031

Global Propofol Drug market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Propofol Drug

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Propofol Drug market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fresenius Kabi, Aspen Pharma, B. Braun, Pfizer, Dr. Reddy's Laboratories, Rusoma, Centurion Healthcare, Wellona Pharma, NEON, Flagship Biotech, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Propofol Drug market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
10 mL
20 mL
50 mL
100 mL

Market segment by Application
General Anesthesia
Medical Procedures Sedation
Mechanical Ventilation
Other

Major players covered
Fresenius Kabi
Aspen Pharma
B. Braun
Pfizer
Dr. Reddy's Laboratories
Rusoma
Centurion Healthcare
Wellona Pharma
NEON
Flagship Biotech
Xi’an Libang Pharmaceutical
Guangdong Jiabo Pharmaceutical
Sichuan Biokin Pharmaceutical
Sichuan Kelun Pharmaceutical
Beijing Sciecure Pharmaceutical
Jiangsu Nhwa Pharmaceutical
Jiangsu Yingke Biopharmaceutical

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Propofol Drug product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Propofol Drug, with price, sales quantity, revenue, and global market share of Propofol Drug from 2020 to 2025.

Chapter 3, the Propofol Drug competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Propofol Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Propofol Drug market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Propofol Drug.

Chapter 14 and 15, to describe Propofol Drug sales channel, distributors, customers, research findings and conclusion.